We also herein confirmed IGF2BP1 to be a promising prognostic indicator in overall invasive breast cancer and in certain subgroups, including histologic types of IDC and postmenopausal subgroups and patients who did not undergo radiotherapy. The gene discussed is IGF2BP1; the disease is invasive breast carcinoma.